Showing 3061-3070 of 5615 results for "".
- Dr. Woolery-Lloyd Appointed Program Development Advisor for Skin of Color Updatehttps://reachmd.com/news/dr-woolery-lloyd-appointed-program-development-advisor-for-skin-of-color-update/2484015/Heather Woolery-Lloyd, MD, FAAD, has been appointed program development advisor for Skin of Color Update, the nation’s largest medical education event focused on dermatologic care for patients with skin of color. Dr. Woolery-Lloyd serves as director of the Skin of Color Division at the Uni
- AI Rewrites the Rules of Multiple Sclerosis: Study Recasts MS as a Disease Continuumhttps://reachmd.com/news/ai-rewrites-the-rules-of-multiple-sclerosis-study-recasts-ms-as-a-disease-continuum/2483865/A landmark study published in Nature Medicine has upended decades of conventional wisdom about multiple sclerosis (MS), proposing that the condition should no
- Genetic Clues May Predict Cannabis-Based Treatment Success in Multiple Sclerosishttps://reachmd.com/news/genetic-clues-may-predict-cannabis-based-treatment-success-in-multiple-sclerosis/2483857/In the quest to personalize therapy for multiple sclerosis (MS), a new study suggests that common genetic variants in drug transporter genes may predict how well patients respond to nabiximo
- Pediatric Asthma Care: The Role of the Budesonide-Formoterol Inhalerhttps://reachmd.com/news/revolutionizing-pediatric-asthma-care-the-role-of-the-budesonide-formoterol-inhaler/2483569/Managing childhood asthma remains challenging, especially during exercise when symptoms can flare; current pediatric guidance (e.g., GINA/NAEPP) recommends addressing exercise-induced bronchoconstriction with appropriate reliever/controller strategies. The budesonide–formoterol inhal
- Positioning Psoriatic Disease in Global Health Policy: A Call to Actionhttps://reachmd.com/news/positioning-psoriatic-disease-in-global-health-policy-a-call-to-action/2483554/Psoriatic disease is increasingly capturing necessary attention in global health policy discussions. Its far-reaching systemic impacts, traditionally marginalized in the narrative of noncommunicable diseases (NCDs), are now demanding inclusion and recognition. Current initiatives un
- Evolving Cardiovascular Risks: Addressing Today's Clinical Challengeshttps://reachmd.com/news/evolving-cardiovascular-risks-addressing-todays-clinical-challenges/2483547/The landscape of cardiovascular risks is shifting significantly, presenting both challenges and opportunities for innovation in public health. In the U.S., based on national surveillance estimates from recent years, about
- CHLA Highlights at the 2025 American Academy of Pediatrics Conferencehttps://reachmd.com/news/chla-highlights-at-the-2025-american-academy-of-pediatrics-conference/2483513/Children’s Hospital Los Angeles (CHLA), one of the nation's top pediatric academic institutions, will once again take center stage at th
- Magnesium Depletion and Cardiovascular Mortality: Unveiling the Connection in Hyperlipidemiahttps://reachmd.com/news/magnesium-depletion-and-cardiovascular-mortality-unveiling-the-connection-in-hyperlipidemia/2483480/A new nationwide study suggests that magnesium depletion may be a significant and underrecognized risk factor for premature death in individuals with hyperlipidemia, a condition affect
- Epicutis Launches Lipid Shield SPF 30https://reachmd.com/news/epicutis-launches-lipid-shield-spf-30/2483432/Epicutis has launched a mineral-based sunscreen, Lipid Shield SPF 30. In a press release, the company stated the Lipid Shield SPF 30 is the only sunscreen to pair non-nano zinc oxide with a proprietary molecule known as disodium tetramethylhexadecenyl succinoyl cysteine (TSC). TSC, a lipid
- Advancing Early Alzheimer's Detection: Integrating Biomarkers and Lifestyle Strategieshttps://reachmd.com/news/advancing-early-alzheimers-detection-integrating-biomarkers-and-lifestyle-strategies/2483404/Detecting Alzheimer's disease in its nascent stages is not only critical but also increasingly viable with the advent of advanced biomarkers. At the forefront is TSPO PET, an imaging biomarker of neuroinflammation that may accompany early Alzheimer’s changes, rather than a disease-specific